Literature DB >> 18559806

Our approach to osteoporosis screening and treatment needs to change.

Mark S Cooper1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18559806      PMCID： PMC2413298          DOI： 10.1503/cmaj.080672

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Bone loss goes beyond estrogen.

Authors:  T John Martin; Dana Gaddy
Journal:  Nat Med       Date:  2006-06       Impact factor: 53.440

Review 2.  Bone quality--the material and structural basis of bone strength and fragility.

Authors:  Ego Seeman; Pierre D Delmas
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

Review 3.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

4.  Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

Authors:  Michele Iannuzzi-Sucich; Karen M Prestwood; Anne M Kenny
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-12       Impact factor: 6.053

5.  Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

Authors:  Joel S Finkelstein; Sarah E Brockwell; Vinay Mehta; Gail A Greendale; MaryFran R Sowers; Bruce Ettinger; Joan C Lo; Janet M Johnston; Jane A Cauley; Michelle E Danielson; Robert M Neer
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

Review 6.  Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment.

Authors:  Kerry Siminoski; William D Leslie; Heather Frame; Anthony Hodsman; Robert G Josse; Aliya Khan; Brian C Lentle; Jacques Levesque; David J Lyons; Giuseppe Tarulli; Jacques P Brown
Journal:  J Clin Densitom       Date:  2007-02-16       Impact factor: 2.617

7.  Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.

Authors:  Mark S Cooper; Elizabeth H Rabbitt; Philippa E Goddard; William A Bartlett; Martin Hewison; Paul M Stewart
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

Review 8.  Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

Authors:  E Seeman
Journal:  Bone       Date:  2007-06-26       Impact factor: 4.398

9.  A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men.

Authors:  B Lawrence Riggs; L Joseph Melton; Richard A Robb; Jon J Camp; Elizabeth J Atkinson; Lisa McDaniel; Shreyasee Amin; Peggy A Rouleau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-02       Impact factor: 6.741

10.  Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents.

Authors:  Claudie Berger; Lisa Langsetmo; Lawrence Joseph; David A Hanley; K Shawn Davison; Robert Josse; Nancy Kreiger; Alan Tenenhouse; David Goltzman
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.